Qube Research & Technologies LTD Arcturus Therapeutics Holdings Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 6,602 shares of ARCT stock, worth $138,774. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,602
Previous 13,242
50.14%
Holding current value
$138,774
Previous $447,000
64.21%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ARCT
# of Institutions
186Shares Held
25.9MCall Options Held
320KPut Options Held
153K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$98.7 Million0.28% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$55.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.96MShares$41.3 Million0.44% of portfolio
-
Nikko Asset Management Americas, Inc.1.56MShares$32.9 Million0.44% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.56MShares$32.9 Million0.03% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $559M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...